April 12, 2009 Bioengineering Professor Luke Lee has received a scholar award from the Siebel Stem Cell Institute, a joint venture between UC Berkeley and the Stanford University School of Medicine.
faculty
Schaffer talks stem cells on YouTube
April 2009 Bioengineering and Chemical Engineering Professor David Schaffer talks about stems cell research and funding from the California Institute for Regenerative Medicine. Watch it on YouTube.
Adams and Keasling direct Berkeley Lab
March 31, 2009 Bioengineering and Chemical Engineering Professor Jay Keasling has been appointed Acting Deputy Laboratory Director of Lawrence Berkeley Lab, and Adjunct Bioengineering Professor Paul Adams has been appointed Acting Director of Berkeley Lab’s Physical Biosciences Division.
Herr’s research is hot stuff
March 28, 2009 An article by Bioengineering Assistant Professor Amy Herr has been declared one of the “Hot Articles of 2008” by Lab On A Chip journal.
Rock Star – Keasling in Rolling Stone
March 18, 2009 Jay Keasling, Professor of Bioengineering and Chemical Engineering, was named one of Rolling Stone Magazine’s 100 Agents of Change.
California Connected Features Keasling
March 16, 2009 Bioengineering and Chemical Engineering Professor Jay Keasling is becoming a fixture on YouTube! In addition to his appearance last week on The Colbert Report, he can also be found on YouTube discussing antimalarial drug research in a video produced by California Connected, an award-winning PBS news magazine.
Keasling on Colbert Report
March 11, 2009 Bioengineering and Chemical Engineering Professor Jay Keasling made a guest appearance on the Colbert Report, a popular Comedy Central news magazine television show last night.
Head-Gordon wins Li Ka Shing grant
February 25, 2009 Bioengineering Professor Teresa Head-Gordon is the recipient of a 2008-2009 Li Ka Shing Foundation Women in Science Research Grant Program.
Schaffer Working To Cure Cystic Fibrosis
February 17, 2009 Professor of Bioengineering and Chemical Engineering David Schaffer, along with researchers from UC Berkeley and the University of Iowa, have turned a relatively benign virus into a highly infectious form that is ideal as a carrier for gene therapy.